Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment

In the present study we investigated the prognostic value of Circulating Tumour Cells (CTC) and their utility for therapy monitoring in non-small cell lung cancer (NSCLC). A total of 43 patients newly diagnosed with NSCLC were prospectively enrolled. Blood samples were obtained before the 1st, 2nd a...

Descripción completa

Detalles Bibliográficos
Autores principales: Muinelo-Romay, Laura, Vieito, Maria, Abalo, Alicia, Alonso Nocelo, Marta, Barón, Francisco, Anido, Urbano, Brozos, Elena, Vázquez, Francisca, Aguín, Santiago, Abal, Miguel, López López, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980598/
https://www.ncbi.nlm.nih.gov/pubmed/24452143
http://dx.doi.org/10.3390/cancers6010153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980598/
https://www.ncbi.nlm.nih.gov/pubmed/24452143
http://dx.doi.org/10.3390/cancers6010153

Ejemplares similares